New drug combo shows promise against prostate cancer in trials
In a phase 3 clinical trial by Pfizer, treatment with talazoparib and enzalutamide lowered the risk of prostate cancer progression or death by 37%.
MEK Enterprises Blog - Blogging, News, Information, and How to Make Money Online
The Number 1 Online Blog Worldwide!
In a phase 3 clinical trial by Pfizer, treatment with talazoparib and enzalutamide lowered the risk of prostate cancer progression or death by 37%.
In this podcast episode, we discuss all things nutrition and endometriosis with Dr. Hana Kahleova, an endocrinologist, and Hannah Alderson, a nutritionist with personal experience of endometriosis.
A study found eating food high in fat and sugar alters the brain’s reward centers to crave these foods and decreases the desire for low-fat foods, increasing obesity risk.
Researchers said they found little difference in survival rates for people with heart failure between diuretic drugs torsemide and furosemide
A recent study in mouse models of depression found that matcha tea extract helped improve depression-like symptoms in te rodents.
A long-term study finds a 97% survival rate among men with prostate cancer at 15 years, regardless of whether the disease was treated or not.
Both progestin-only and combined hormonal contraceptives may increase the risk of breast cancer, a study finds.
A new study has found that a focused ultrasound treatment can improve Parkinson’s disease symptoms, such as uncontrolled movement and motor impairment, for up to 1 year.
Researchers say programs allowing pharmacists to work with physicians to dispense medications for opioid use disorder could be beneficial to patients
A new study has found genetic links between endometriosis and several chronic pain and inflammatory conditions, including migraine, chronic back pain, and osteoarthritis.